SEC 13F Intelligence

Assenagon Asset Management S.A. / REGN

Assenagon Asset Management S.A.’s Regeneron Pharmaceuticals Position

Does Assenagon Asset Management S.A. own Regeneron Pharmaceuticals (REGN)? Yes — 244.9K shares worth $153M (+0.19% of its 13F portfolio) as of Q2 2026, up from 207.8K shares the prior filed quarter.

Position Value
$153M
Q2 2026
Shares
244.9K
% of Portfolio
+0.19%
Quarters Held
30
currently held

Position History REGN

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $40MQ2 ’19: $32MQ3 ’19: $9MQ4 ’19: $11MQ4 ’19Q1 ’20: $615,000Q2 ’20: $22MQ4 ’20: $75MQ1 ’21: $91MQ1 ’21Q2 ’21: $5MQ3 ’21: $24MQ4 ’21: $19MQ1 ’22: $46MQ1 ’22Q2 ’22: $42MQ3 ’22: $57MQ4 ’22: $88MQ1 ’23: $167MQ1 ’23Q2 ’23: $85MQ3 ’23: $78MQ4 ’23: $190MQ1 ’24: $183MQ1 ’24Q2 ’24: $135MQ3 ’24: $182MQ4 ’24: $127MQ1 ’25: $305MQ1 ’25Q2 ’25: $222MQ3 ’25: $269MQ4 ’25: $180MQ1 ’26: $161MQ1 ’26Q2 ’26: $153Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026244.9K$153M+0.19%
Q1 2026207.8K$161M+0.24%
Q4 2025233.2K$180M+0.25%
Q3 2025477.8K$269M+0.37%
Q2 2025423.3K$222M+0.33%
Q1 2025481.4K$305M+0.51%
Q4 2024177.6K$127M+0.20%
Q3 2024172.9K$182M+0.33%
Q2 2024128.4K$135M+0.30%
Q1 2024189.7K$183M+0.43%
Q4 2023216.5K$190M+0.50%
Q3 202394.4K$78M+0.24%
Q2 2023118.3K$85M+0.29%
Q1 2023203.3K$167M+0.59%
Q4 2022122.0K$88M+0.32%
Q3 202283.0K$57M+0.22%
Q2 202270.3K$42M+0.15%
Q1 202265.5K$46M+0.13%
Q4 202130.2K$19M+0.06%
Q3 202140.4K$24M+0.08%
Q2 20219.1K$5M+0.02%
Q1 2021191.7K$91M+0.37%
Q4 2020156.3K$75M+0.33%
Q2 202034.7K$22M+0.14%
Q1 20201.3K$615,0000.00%
Q4 201928.3K$11M+0.07%
Q3 201934.2K$9M+0.06%
Q2 2019101.6K$32M+0.24%
Q1 201997.8K$40M+0.38%
Q4 201835.8K$13M+0.15%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of REGN.